Wenqing Yao 4
4 · INCYTE CORP · Filed Jan 27, 2021
Insider Transaction Report
Form 4
INCYTE CORPINCY
Wenqing Yao
Ex VP Discovery Medicinal Chem
Transactions
- Sale
Common Stock
2021-01-25$100.00/sh−19,986$1,998,600→ 143,784 total - Exercise/Conversion
Common Stock
2021-01-25$73.21/sh+19,986$1,463,175→ 163,770 total - Exercise/Conversion
Common Stock
2021-01-25$73.21/sh+1,559$114,134→ 145,343 total - Sale
Common Stock
2021-01-25$100.00/sh−1,559$155,900→ 143,784 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2021-01-25−1,559→ 0 totalExercise: $73.21Exp: 2022-01-07→ Common Stock (1,559 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-01-25−19,986→ 0 totalExercise: $73.21Exp: 2022-01-07→ Common Stock (19,986 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- [F2]This includes an aggregate of 108,222 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
- [F3]Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.